Natixis Advisors, L.P. Moderna, Inc. Transaction History

Natixis Advisors, L.P.

$54.1 Billion
Q1 2025

A detailed history of Natixis Advisors, L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 17,761 shares of MRNA stock, worth $472,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,761

Previous 10,405 70.7%

Holding current value

$472,620

Previous $433,000 16.4%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$28.35 - $47.53 $208,542 - $349,630	7,356 Added 70.7%	17,761 $504,000
Q4 2024 Feb 10, 2025	SELL	$36.85 - $63.93 $43,077 - $74,734	-1,169 Reduced 10.1%	10,405 $433,000
Q3 2024 Nov 06, 2024	SELL	$63.64 - $125.14 $3.75 Million - $7.38 Million	-58,936 Reduced 83.59%	11,574 $773,000
Q2 2024 Aug 01, 2024	BUY	$101.21 - $166.61 $4.05 Million - $6.67 Million	40,021 Added 131.26%	70,510 $8.37 Million
Q1 2024 Apr 25, 2024	BUY	$85.37 - $115.44 $501,719 - $678,440	5,877 Added 23.88%	30,489 $3.25 Million
Q4 2023 Feb 06, 2024	BUY	$69.51 - $104.43 $325,862 - $489,567	4,688 Added 23.53%	24,612 $2.45 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $319,117 - $419,079	3,310 Added 19.92%	19,924 $2.06 Million
Q2 2023 Aug 15, 2023	SELL	$118.5 - $160.53 $1.51 Million - $2.04 Million	-12,709 Reduced 43.34%	16,614 $2.02 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $77,733 - $112,892	573 Added 1.99%	29,323 $4.5 Million
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $392,192 - $695,862	3,313 Added 13.02%	28,750 $5.16 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $1.6 Million - $2.64 Million	13,586 Added 114.64%	25,437 $3.01 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $185,768 - $280,071	-1,586 Reduced 11.8%	11,851 $1.69 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $401,889 - $746,988	3,178 Added 30.98%	13,437 $2.32 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $15.2 Million - $24.8 Million	-67,297 Reduced 86.77%	10,259 $2.61 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $32.4 Million - $70.7 Million	-145,991 Reduced 65.31%	77,556 $29.8 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $29 Million - $52.5 Million	223,547 New	223,547 $52.5 Million

Others Institutions Holding MRNA

# of Institutions

861

Shares Held

251M

Call Options Held

23.9M

Put Options Held

30.2M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Moderna, Inc. Transaction History